2001
DOI: 10.1016/s0264-410x(01)00389-9
|View full text |Cite
|
Sign up to set email alerts
|

Enhanced CD8+ T cell immune response against a V3 loop multi-epitope polypeptide (TAB13) of HIV-1 Env after priming with purified fusion protein and booster with modified vaccinia virus Ankara (MVA-TAB) recombinant: a comparison of humoral and cellular immune responses with the vaccinia virus Western Reserve (WR) vector

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
17
0

Year Published

2003
2003
2008
2008

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 25 publications
(19 citation statements)
references
References 52 publications
2
17
0
Order By: Relevance
“…We therefore found that in this system not all heterologous prime-boost combinations result in significant CD8 ϩ T cell expansion and that vaccinia vectors have the unusual property of boosting specific CD8 ϩ T cell responses. These observations are consistent with our own previous data and data from various other laboratories working on a variety of systems (3,(25)(26)(27)(28).…”
Section: A Vaccinia Vector Is Capable Of Expanding Memory Cd8 T Cellssupporting
confidence: 93%
See 1 more Smart Citation
“…We therefore found that in this system not all heterologous prime-boost combinations result in significant CD8 ϩ T cell expansion and that vaccinia vectors have the unusual property of boosting specific CD8 ϩ T cell responses. These observations are consistent with our own previous data and data from various other laboratories working on a variety of systems (3,(25)(26)(27)(28).…”
Section: A Vaccinia Vector Is Capable Of Expanding Memory Cd8 T Cellssupporting
confidence: 93%
“…We do not address this directly here, although a number of previous studies suggest that viral replication may not be crucial for boosting. We have shown that Flu-ME delivered intranasally (allowing it to replicate in the lung epithelium) does not efficiently boost immune responses (14,24), whereas studies comparing the ability of live and attenuated vaccinia to generate responses against HIV epitopes showed that the attenuated virus was in fact the better boosting vector (26,27).…”
Section: Discussionmentioning
confidence: 96%
“…However, this is the first illustration that rFPV can be used to elicit a protective CD8 ϩ T cell response in the malaria model, and that FP9 is more immunogenic than a similar attenuated FPV vaccine strain. Previous studies have shown that attenuated rVVs are more immunogenic delivery systems than their nonattenuated counterparts (36,37). In addition, MVA, which was derived by serial passage from a nonattenuated VV, is reported to elicit more potent T cell responses against the PbCS Ag than the rationally attenuated NY-VAC strain (13).…”
Section: Discussionmentioning
confidence: 99%
“…Future studies should be implemented with Env immunogens that can elicit cross-clade, neutralizing antibodies (9,49,57,67), and therefore these titers can then be raised by coupling to C3d. In addition, future studies can explore the use of recombinant viral vectors (e.g., modified vaccinia virus Ankara [1,3,21,25,44,45]), adenovirus 5 (15), or alphavirus (13,64), which are being used in many preclinical AIDS vaccine studies. The introduction of C3d fused immunogens into these viral vectors could be a more effective strategy for enhancing immune responses.…”
Section: Discussionmentioning
confidence: 99%